Weston, MA, United States of America

Michael J Macphee

This inventor holds 1 USPTO granted patent. Top assignees: Biogen Ma Inc., Sunesis Pharmaceuticals, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael J Macphee. Retrieved from https://idiyas.com/inventor/michael-j-macphee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael J. Macphee: Innovator in Biotechnology

Introduction: Michael J. Macphee, located in Weston, MA, is an influential figure in the field of biotechnology. With a focus on therapeutic advancements, he has made significant contributions to the understanding of Bruton's tyrosine kinase, an important target in various diseases.

Latest Patents: Michael holds a patent titled "Inhibitors of Bruton's Tyrosine Kinase." This innovative invention provides a compound, solid forms, and compositions that serve as effective inhibitors of Bruton's tyrosine kinase. The patent outlines methods for producing these compounds, which exhibit desirable characteristics for their intended use.

Career Highlights: Over the years, Michael has lent his expertise to several prominent companies in the biotechnology sector. Notably, he has worked at Biogen MA Inc. and Sunesis Pharmaceuticals, Inc., where he contributed to the development of cutting-edge medical treatments.

Collaborations: Michael has collaborated with esteemed colleagues, including Brian T. Hopkins and Xiongwei Cai. These partnerships have facilitated significant advancements in research and development within his field.

Conclusion: Michael J. Macphee's work stands as a testament to the critical role of innovation in biotechnology. His advancements in Bruton's tyrosine kinase inhibitors highlight his dedication to improving therapeutic options and solidify his place as a key contributor to medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…